Live Breaking News & Updates on Fennec Pharmaceuticals|Page 15
Stay updated with breaking news from Fennec pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, August 3rd. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Fennec Pharmaceuticals (NASDAQ:FENC – […] ....
RESEARCH TRIANGLE PARK, N.C., July 31, 2023 Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will release its second quarter. ....
RESEARCH TRIANGLE PARK, N.C., July 31, 2023 (GLOBE NEWSWIRE) Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its ....
TScan Therapeutics (NASDAQ:TCRX – Get Free Report) and Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, risk, dividends and earnings. Profitability This table compares TScan Therapeutics and […] ....
Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) shares crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$11.34 and traded as low as C$11.27. Fennec Pharmaceuticals shares last traded at C$11.27, with a volume of 100 shares trading hands. Fennec Pharmaceuticals Stock […] ....